SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001437749-18-006786
Filing Date
2018-04-12
Accepted
2018-04-12 16:33:45
Documents
3
Effectiveness Date
2018-04-12

Document Format Files

Seq Description Document Type Size
1 FORM DEFA14A kmph20180409_defa14a.htm DEFA14A 15255
2 a2.jpg GRAPHIC 243752
3 a1.jpg GRAPHIC 210804
  Complete submission text file 0001437749-18-006786.txt   642499
Mailing Address 2500 CROSSPARK ROAD, SUITE E126 CORALVILLE IA 52241
Business Address 2500 CROSSPARK ROAD, SUITE E126 CORALVILLE IA 52241 319-665-2575
KEMPHARM, INC (Filer) CIK: 0001434647 (see all company filings)

IRS No.: 205894398 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36913 | Film No.: 18752411
SIC: 2834 Pharmaceutical Preparations